Ken Griffin Anika Therapeutics, Inc. Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$24.57 - $28.47 $78,624 - $91,104	-3,200 Reduced 54.24%	2,700 $68,000
Q1 2024 May 15, 2024	BUY	$21.95 - $26.42 $70,240 - $84,544	3,200 Added 118.52%	5,900 $149,000
Q4 2023 Feb 14, 2024	BUY	$18.47 - $23.3 $33,246 - $41,940	1,800 Added 200.0%	2,700 $61,000
Q3 2023 Nov 14, 2023	SELL	$16.98 - $26.1 $619,770 - $952,650	-36,500 Reduced 97.59%	900 $16,000
Q2 2023 Aug 14, 2023	SELL	$25.16 - $28.86 $188,700 - $216,450	-7,500 Reduced 16.7%	37,400 $971,000
Q1 2023 May 15, 2023	BUY	$25.91 - $32.1 $93,276 - $115,560	3,600 Added 8.72%	44,900 $1.29 Million
Q4 2022 Feb 14, 2023	SELL	$23.85 - $31.91 $78,705 - $105,303	-3,300 Reduced 7.4%	41,300 $1.22 Million
Q3 2022 Nov 14, 2022	BUY	$21.74 - $24.68 $969,603 - $1.1 Million	44,600 New	44,600 $1.06 Million

118

11.9M

2.7K

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $358M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.